Federal award (DEFINITIVE CONTRACT, fiscal year 2024)
Recipient: PATHCISION MEDICINE, INC.
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2025-08-11 to 2026-08-10
Current total value of award: $354941
Description: SBIR CONCEPT AWARD FOR A NOVEL DELIVERY APPROACH TO TRANSFORM METASTATIC PANCREATIC CANCER TREATMENT AND PREVENTION